Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review Tian-Jia Liu et al, 2021, Frontiers in Oncology CrossRef
Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin Esra Küpeli Akkol et al, 2021, Cancers CrossRef
Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK Weilong Li et al, 2021, Experimental and Therapeutic Medicine CrossRef
Advances in the treatment of pancreatic cancer with traditional Chinese medicine Yanhua Zhang et al, 2023, Frontiers in Pharmacology CrossRef
Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
Hongfei Tong et al, 2020, OncoTargets and Therapy CrossRef
Therapeutic Potential of Emodin for Gastrointestinal Cancers Sierra J. McDonald et al, 2022, Integrative Cancer Therapies CrossRef
Phyto-targeting the CEMIP Expression as a Strategy to Prevent Pancreatic Cancer Metastasis Loganayaki Periyasamy et al, 2022, Current Pharmaceutical Design CrossRef
NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer Tao Qin et al, 2020, Frontiers in Oncology CrossRef
Marine Anthraquinones: Pharmacological and Toxicological Issues Giulia Greco et al, 2021, Marine Drugs CrossRef
Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease James H. Monkman et al, 2019, Cancers CrossRef